These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3172486)

  • 1. [Chromosome abnormalities in early cancers].
    Maeda S; Horio M; Kitazawa S; Sugiyama T
    Gan No Rinsho; 1988 Aug; 34(10):1264-72. PubMed ID: 3172486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome abnormalities in the myelodysplastic syndromes.
    Heim S; Mitelman F
    Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes.
    Atkin NB; Baker MC
    J Natl Cancer Inst; 1966 Mar; 36(3):539-57. PubMed ID: 18630328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific chromosomal changes (aberrations)--supplementary marker of malignant degeneration in oncomorphologic studies].
    Anichkov NM; Mamaev NN; Mamaeva SE; Skripnik SV
    Arkh Patol; 1986; 48(6):87-91. PubMed ID: 3530204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome changes in human malignant diseases.
    Van den Berghe H
    Prog Clin Biol Res; 1983; 132C():279-90. PubMed ID: 6579565
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromosomal abnormalities in leukemia.
    Cork A
    Am J Med Technol; 1983 Oct; 49(10):703-14. PubMed ID: 6359878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetics of myelodysplastic syndromes.
    Mecucci C; La Starza R
    Forum (Genova); 1999; 9(1):4-13. PubMed ID: 10101207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia.
    McDonell N; Ramser J; Francis F; Vinet MC; Rider S; Sudbrak R; Riesselman L; Yaspo ML; Reinhardt R; Monaco AP; Ross F; Kahn A; Kearney L; Buckle V; Chelly J
    Genomics; 2000 Mar; 64(3):221-9. PubMed ID: 10756090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosomal changes in cancers].
    Sakaki MS
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):781-8. PubMed ID: 6372697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of cytogenetics in leukemias.
    VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
    Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.
    Barouk-Simonet E; Soenen-Cornu V; Roumier C; Cosson A; Laï JL; Fenaux P; Preudhomme C
    Cancer Genet Cytogenet; 2005 Mar; 157(2):118-26. PubMed ID: 15721632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonrandom chromosomal changes in human solid tumors: application of an improved culture method.
    Teyssier JR
    J Natl Cancer Inst; 1987 Dec; 79(6):1189-98. PubMed ID: 3480370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A FISH comparison of variant derivatives of the recurrent dic(17;20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes.
    MacKinnon RN; Patsouris C; Chudoba I; Campbell LJ
    Genes Chromosomes Cancer; 2007 Jan; 46(1):27-36. PubMed ID: 17048234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal mechanisms in neoplasia.
    de la Chapelle A
    Prog Clin Biol Res; 1985; 177():139-52. PubMed ID: 3892538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.